Clinical Trial Update: Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating natural killer cells as part of donor stem cell transplantation for various myeloid leukemias and myelodysplastic syndromes; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Natural killer cells (donor-derived NK cells) (natural killer cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-17